Literature DB >> 19226165

Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids.

Won Jun Choi1, Sung-Eun Kim, Andrew G Stephen, Iwona Weidlich, Alessio Giubellino, Fa Liu, Karen M Worthy, Lakshman Bindu, Matthew J Fivash, Marc C Nicklaus, Donald P Bottaro, Robert J Fisher, Terrence R Burke.   

Abstract

A fluorescence anisotropy (FA) competition-based Shc Src homology 2 (SH2) domain-binding was established using the high affinity fluorescein isothiocyanate (FITC) containing peptide, FITC-NH-(CH2)4-CO-pY-Q-G-L-S-amide (8; Kd = 0.35 microM). Examination of a series of open-chain bis-alkenylamide containing peptides, prepared as ring-closing metathesis precursors, showed that the highest affinities were obtained by replacement of the original Gly residue with N alpha-substituted Gly (NSG) "peptoid" residues. This provided peptoid-peptide hybrids of the form "Ac-pY-Q-[NSG]-L-amide." Depending on the NSG substituent, certain of these hybrids exhibited up to 40-fold higher Shc SH2 domain-binding affinity than the parent Gly-containing peptide (IC50 = 248 microM) (for example, for N-homoallyl analogue 50, IC50 = 6 microM). To our knowledge, this work represents the first successful example of the application of peptoid-peptide hybrids in the design of SH2 domain-binding antagonists. These results could provide a foundation for further structural optimization of Shc SH2 domain-binding peptide mimetics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226165      PMCID: PMC2669314          DOI: 10.1021/jm800789h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

Review 1.  The Src homology-2 domains (SH2 domains) of the protein tyrosine kinase p56lck: structure, mechanism and drug design.

Authors:  R J Broadbridge; R P Sharma
Journal:  Curr Drug Targets       Date:  2000-12       Impact factor: 3.465

Review 2.  Molecular recognition by SH2 domains.

Authors:  J Michael Bradshaw; Gabriel Waksman
Journal:  Adv Protein Chem       Date:  2002

3.  Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic.

Authors:  Shinya Oishi; Rajeshri G Karki; Zhen-Dan Shi; Karen M Worthy; Lakshman Bindu; Oleg Chertov; Dominic Esposito; Peter Frank; William K Gillette; Melissa Maderia; James Hartley; Marc C Nicklaus; Joseph J Barchi; Robert J Fisher; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2005-04-01       Impact factor: 3.641

Review 4.  The SH2 domain: versatile signaling module and pharmaceutical target.

Authors:  Kazuya Machida; Bruce J Mayer
Journal:  Biochim Biophys Acta       Date:  2004-11-19

5.  Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles.

Authors:  Shinya Oishi; Zhen-Dan Shi; Karen M Worthy; Lakshman K Bindu; Robert J Fisher; Terrence R Burke
Journal:  Chembiochem       Date:  2005-04       Impact factor: 3.164

6.  Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.

Authors:  M M Zhou; J E Harlan; W S Wade; S Crosby; K S Ravichandran; S J Burakoff; S W Fesik
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

7.  Ring-closing metathesis of olefinic peptides: design, synthesis, and structural characterization of macrocyclic helical peptides.

Authors:  H E Blackwell; J D Sadowsky; R J Howard; J N Sampson; J A Chao; W E Steinmetz; D J O'Leary; R H Grubbs
Journal:  J Org Chem       Date:  2001-08-10       Impact factor: 4.354

8.  ShcA signalling is essential for tumour progression in mouse models of human breast cancer.

Authors:  Josie Ursini-Siegel; W Rod Hardy; Dongmei Zuo; Sonya H L Lam; Virginie Sanguin-Gendreau; Robert D Cardiff; Tony Pawson; William J Muller
Journal:  EMBO J       Date:  2008-02-14       Impact factor: 11.598

9.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.

Authors:  A G Batzer; D Rotin; J M Ureña; E Y Skolnik; J Schlessinger
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Development of Grb2 SH2 Domain Signaling Antagonists: A Potential New Class of Antiproliferative Agents.

Authors:  Terrence R Burke
Journal:  Int J Pept Res Ther       Date:  2006-03-14       Impact factor: 1.931

View more
  2 in total

1.  Targeting Oncogenic Src Homology 2 Domain-Containing Phosphatase 2 (SHP2) by Inhibiting Its Protein-Protein Interactions.

Authors:  Sara Bobone; Luca Pannone; Barbara Biondi; Maja Solman; Elisabetta Flex; Viviana Claudia Canale; Paolo Calligari; Chiara De Faveri; Tommaso Gandini; Andrea Quercioli; Giuseppe Torini; Martina Venditti; Antonella Lauri; Giulia Fasano; Jelmer Hoeksma; Valerio Santucci; Giada Cattani; Alessio Bocedi; Giovanna Carpentieri; Valentina Tirelli; Massimo Sanchez; Cristina Peggion; Fernando Formaggio; Jeroen den Hertog; Simone Martinelli; Gianfranco Bocchinfuso; Marco Tartaglia; Lorenzo Stella
Journal:  J Med Chem       Date:  2021-10-29       Impact factor: 7.446

2.  Gene-centric meta-analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations.

Authors:  Sachiko Yoneyama; Yiran Guo; Matthew B Lanktree; Michael R Barnes; Clara C Elbers; Konrad J Karczewski; Sandosh Padmanabhan; Florianne Bauer; Jens Baumert; Amber Beitelshees; Gerald S Berenson; Jolanda M A Boer; Gregory Burke; Brian Cade; Wei Chen; Rhonda M Cooper-Dehoff; Tom R Gaunt; Christian Gieger; Yan Gong; Mathias Gorski; Nancy Heard-Costa; Toby Johnson; Michael J Lamonte; Caitrin McDonough; Keri L Monda; N Charlotte Onland-Moret; Christopher P Nelson; Jeffrey R O'Connell; Jose Ordovas; Inga Peter; Annette Peters; Jonathan Shaffer; Haiqinq Shen; Erin Smith; Liz Speilotes; Fridtjof Thomas; Barbara Thorand; W M Monique Verschuren; Sonia S Anand; Anna Dominiczak; Karina W Davidson; Robert A Hegele; Iris Heid; Marten H Hofker; Gordon S Huggins; Thomas Illig; Julie A Johnson; Susan Kirkland; Wolfgang König; Taimour Y Langaee; Jeanne McCaffery; Olle Melander; Braxton D Mitchell; Patricia Munroe; Sarah S Murray; George Papanicolaou; Susan Redline; Muredach Reilly; Nilesh J Samani; Nicholas J Schork; Yvonne T Van Der Schouw; Daichi Shimbo; Alan R Shuldiner; Martin D Tobin; Cisca Wijmenga; Salim Yusuf; Hakon Hakonarson; Leslie A Lange; Ellen W Demerath; Caroline S Fox; Kari E North; Alex P Reiner; Brendan Keating; Kira C Taylor
Journal:  Hum Mol Genet       Date:  2013-12-17       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.